A second look at bivalirudin.
Antman
E M
EM
Braunwald
E
E
D015906:Angioplasty, Balloon, Coronary; D000991:Antithrombins / Q000191:economics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D003362:Cost-Benefit Analysis; D003627:Data Interpretation, Statistical; D024764:Hirudin Therapy; D006629:Hirudins / Q000031:analogs & derivatives* / Q000191:economics; D006801:Humans; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000517:prevention & control*; D016017:Odds Ratio; D010446:Peptide Fragments / Q000191:economics / Q000627:therapeutic use*; D011859:Radiography; D011994:Recombinant Proteins / Q000191:economics / Q000627:therapeutic use*; D012008:Recurrence; D012107:Research Design; D016896:Treatment Outcome
D000991:Antithrombins; D006629:Hirudins; D010446:Peptide Fragments; D011994:Recombinant Proteins; C074619:bivalirudin